Northwest Biotherapeutics Company Profile (NASDAQ:NWBO)

About Northwest Biotherapeutics

Northwest Biotherapeutics logoNorthwest Biotherapeutics, Inc. is a biotechnology company. The Company is focused on developing immunotherapy products to treat cancer. One of the product lines (DCVax-L) is designed to cover all solid tumor cancers in which the tumors can be surgically removed. Another product line (DCVax-Direct) is designed for all solid tumor cancers. The Company's lead product, DCVax-L, is in an ongoing Phase III trial for diagnosed Glioblastome multiforme (GBM), with over 60 trial sites. Its second product, DCVax-Direct, is being studied in a 60-patient Phase I/II trial for all types of inoperable solid tumors. The 40-patient Phase I stage of the trial has been completed. The Company is working on preparations for Phase II trials of DCVax-Direct. The Company's platform technology, DCVax, uses activated dendritic cells to mobilize a patient's own immune system, including T cells, B cells and antibodies and natural killer cells, among others to attack cancer cells to attack their cancer.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: NWBO
  • CUSIP:
Key Metrics:
  • Previous Close: $0.33
  • 50 Day Moving Average: $0.449
  • 200 Day Moving Average: $1.089
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.21
  • P/E Growth: 0.000
  • Market Cap: $37.76M
  • Outstanding Shares: 113,742,000
  • Beta: 2.09
Additional Links:
Companies Related to Northwest Biotherapeutics:

Analyst Ratings

Consensus Ratings for Northwest Biotherapeutics (NASDAQ:NWBO) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: $2.10 (532.53% upside)

Analysts' Ratings History for Northwest Biotherapeutics (NASDAQ:NWBO)
Show:
DateFirmActionRatingPrice TargetDetails
2/29/2016S&P Equity ResearchBoost Price Target$1.80 -> $2.10View Rating Details
(Data available from 8/25/2014 forward)

Earnings

Earnings History for Northwest Biotherapeutics (NASDAQ:NWBO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/19/2014Q314($0.35)ViewN/AView Earnings Details
8/20/2014($0.29)($0.53)ViewN/AView Earnings Details
5/21/2014($0.33)($0.46)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Northwest Biotherapeutics (NASDAQ:NWBO)
Current Year EPS Consensus Estimate: $-1.850 EPS
Next Year EPS Consensus Estimate: $-1.600 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.25)($0.25)($0.25)
Q2 20161($0.29)($0.29)($0.29)
Q3 20161($0.12)($0.12)($0.12)
Q4 20161($0.12)($0.12)($0.12)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Northwest Biotherapeutics (NASDAQ:NWBO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Northwest Biotherapeutics (NASDAQ:NWBO)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Northwest Biotherapeutics (NASDAQ:NWBO)
DateHeadline
News IconNorthwest Biotherapeutics, Inc (NASDAQ:NWBO): Our Take On The Recent 8K (NASDAQ:NWBO)
streetregister.com - August 25 at 11:41 AM
biz.yahoo.com logoNORTHWEST BIOTHERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Eq (NASDAQ:NWBO)
biz.yahoo.com - August 23 at 11:00 AM
News IconNorthwest Biotherapeutics, Inc (NASDAQ:NWBO) Might Not Be In As Much Trouble As Many Believe - Street Register (NASDAQ:NWBO)
streetregister.com - August 21 at 10:38 AM
finance.yahoo.com logoNORTHWEST BIOTHERAPEUTICS INC Financials (NASDAQ:NWBO)
finance.yahoo.com - August 19 at 6:29 PM
News IconNorthwest Biotherapeutics, Inc (NASDAQ:NWBO) Might Not Be In As Much Trouble As Many Believe (NASDAQ:NWBO)
streetregister.com - August 19 at 9:37 AM
capitalcube.com logoETF’s with exposure to Northwest Biotherapeutics, Inc. : August 16, 2016 (NASDAQ:NWBO)
www.capitalcube.com - August 16 at 6:41 PM
capitalcube.com logoNorthwest Biotherapeutics, Inc. :NWBO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016 (NASDAQ:NWBO)
www.capitalcube.com - August 15 at 6:52 PM
thestreet.com logoShort of Cash, Northwest Bio Flirts With Insolvency (NASDAQ:NWBO)
www.thestreet.com - August 11 at 7:00 PM
biz.yahoo.com logoNORTHWEST BIOTHERAPEUTICS INC Files SEC form 10-Q, Quarterly Report (NASDAQ:NWBO)
biz.yahoo.com - August 9 at 6:49 PM
News IconAnalyzing Analyst Recommendations: Northwest Biotherapeutics, Inc. (NASDAQ:NWBO), PayPal Holdings, Inc ... - TWN (NASDAQ:NWBO)
thewellesleysnews.com - August 5 at 6:44 PM
equities.com logoNorthwest Biotherapeutics Inc. (NWBO) Jumps 6.64% on August 03 - Equities.com (NASDAQ:NWBO)
www.equities.com - August 5 at 6:44 PM
capitalcube.com logoETF’s with exposure to Northwest Biotherapeutics, Inc. : August 5, 2016 (NASDAQ:NWBO)
www.capitalcube.com - August 5 at 6:44 PM
equities.com logoNorthwest Biotherapeutics Inc. (NWBO) Hits New 52-week Low During August 01 Session - Equities.com (NASDAQ:NWBO)
www.equities.com - August 3 at 9:50 AM
News IconWhy Northwest Biotherapeutics, Inc (NASDAQ:NWBO) Shares Jumped in After-Hours Trading - Small Cap Exclusive (press release) (NASDAQ:NWBO)
smallcapexclusive.com - July 27 at 9:36 AM
News IconShares Experiencing a Downtrend: Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) - TGP (NASDAQ:NWBO)
telanaganapress.com - July 17 at 5:58 PM
fiscalstandard.com logoNorthwest Biotherapeutics, Inc. (NWBO) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:NWBO)
www.fiscalstandard.com - July 17 at 5:58 PM
News IconNorthwest Biotherapeutics, Inc (NASDAQ:NWBO) Is In a Real Mess, But Are There Better Days To Come? - Insider Financial (NASDAQ:NWBO)
www.insiderfinancial.com - July 17 at 5:58 PM
equities.com logoNorthwest Biotherapeutics Inc. (NWBO) Hits New 52-week Low During July 13 Session - Equities.com (NASDAQ:NWBO)
www.equities.com - July 15 at 11:27 AM
streetupdates.com logoNotable Buzzers: Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) , Grifols, S.A. (NASDAQ:GRFS) - Street Updates (NASDAQ:NWBO)
www.streetupdates.com - July 12 at 6:51 PM
biz.yahoo.com logoNORTHWEST BIOTHERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements an (NASDAQ:NWBO)
biz.yahoo.com - July 11 at 5:26 PM
kcregister.com logoNews Buzz: Genocea Biosciences, Inc. (NASDAQ:GNCA), Northwest Biotherapeutics, Inc. (NASDAQ:NWBO), The ... - KC Register (NASDAQ:NWBO)
www.kcregister.com - July 11 at 11:10 AM
streetupdates.com logoTake a look at Analyst Tips: Gilead Sciences, Inc. (NASDAQ:GILD) , Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) - Street Updates (NASDAQ:NWBO)
www.streetupdates.com - July 6 at 11:09 AM
smarteranalyst.com logoCompany Update (NASDAQ:NWBO): Northwest Biotherapeutics, Inc Announced a Registered Direct Offering of $3.7 ... - Smarter Analyst (NASDAQ:NWBO)
www.smarteranalyst.com - July 6 at 11:09 AM
publicnow.com logoNW Bio Announced a Registered Direct Offering of $3.7 Million With New Institutional Investors (NASDAQ:NWBO)
www.publicnow.com - July 5 at 9:21 AM
finance.yahoo.com logo9:01 am Northwest Biotherapeutics announces a $3.7 mln registered direct offering for 7.4 mln shares of common stock at $0.50/share (NASDAQ:NWBO)
finance.yahoo.com - July 5 at 9:01 AM
finance.yahoo.com logoNW BIO ANNOUNCES A REGISTERED DIRECT OFFERING OF $3.7 MILLION WITH NEW INSTITUTIONAL INVESTORS (NASDAQ:NWBO)
finance.yahoo.com - July 5 at 9:00 AM
streetinsider.com logoNorthwest Biotherapeutics (NWBO) Announces 180-Day Grace Period Relating to Non-Compliance With Nasdaq Bid ... - StreetInsider.com (NASDAQ:NWBO)
www.streetinsider.com - July 2 at 9:21 AM
fiscalstandard.com logoRecently Issued Stock Ratings For Northwest Biotherapeutics, Inc. (NWBO) - Fiscal Standard (NASDAQ:NWBO)
www.fiscalstandard.com - July 2 at 9:21 AM
finance.yahoo.com logoNW Bio Enters First 180-Day Grace Period Relating To Non-Compliance With Nasdaq $1.00 Per Share Bid Requirement (NASDAQ:NWBO)
finance.yahoo.com - June 30 at 5:25 PM
biz.yahoo.com logoNORTHWEST BIOTHERAPEUTICS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule (NASDAQ:NWBO)
biz.yahoo.com - June 30 at 5:22 PM
equities.com logoNorthwest Biotherapeutics Inc. (NWBO) Jumps 6.43% on June 28 - Equities.com (NASDAQ:NWBO)
www.equities.com - June 29 at 6:26 PM
4-traders.com logoUltragenyx Pharmaceutical : Pre-Market Review on Biotechnology Equities -- Northwest Biotherapeutics, Titan Pharma, Ultragenyx Pharma, and Athersys (NASDAQ:NWBO)
www.4-traders.com - June 29 at 9:24 AM
prnewswire.com logoPre-Market Review on Biotechnology Equities -- Northwest Biotherapeutics, Titan Pharma, Ultragenyx Pharma, and Athersys (NASDAQ:NWBO)
www.prnewswire.com - June 29 at 9:24 AM
equities.com logoNorthwest Biotherapeutics Inc. (NWBO) Jumps 18.36% on June 23 - Equities.com (NASDAQ:NWBO)
www.equities.com - June 26 at 11:05 AM
equities.com logoNorthwest Biotherapeutics Inc. (NWBO) Drops 5.21% on June 21 - Equities.com (NASDAQ:NWBO)
www.equities.com - June 22 at 6:28 PM
capitalcube.com logoETF’s with exposure to Northwest Biotherapeutics, Inc. : June 20, 2016 (NASDAQ:NWBO)
www.capitalcube.com - June 20 at 2:57 PM
fiscalstandard.com logoNorthwest Biotherapeutics, Inc. (NWBO) Analyst Price Targets For The Coming Week - Fiscal Standard (NASDAQ:NWBO)
www.fiscalstandard.com - June 20 at 8:11 AM
equities.com logoNorthwest Biotherapeutics Inc. (NWBO) Hits New 52-week Low During June 16 Session - Equities.com (NASDAQ:NWBO)
www.equities.com - June 18 at 10:46 AM
finance.yahoo.com logoNW Bio Announces Scientific Advisory Board (NASDAQ:NWBO)
finance.yahoo.com - June 13 at 9:15 AM
equities.com logoNorthwest Biotherapeutics Inc. (NWBO) Drops 9.89% on June 07 - Equities.com (NASDAQ:NWBO)
www.equities.com - June 9 at 9:30 AM
ft.com logo[$$] Neil Woodford eyes new equity fund launch (NASDAQ:NWBO)
www.ft.com - June 8 at 10:19 AM
equities.com logoNorthwest Biotherapeutics Inc. (NWBO) is Trading Higher on Unusual Volume for June 06 - Equities.com (NASDAQ:NWBO)
www.equities.com - June 8 at 9:32 AM
streetupdates.com logoAnalysts Rating Alert: Mylan N.V. (NASDAQ:MYL) , Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) - Street Updates (NASDAQ:NWBO)
www.streetupdates.com - June 7 at 6:46 PM
News IconEarnings Review: Northwest Biotherapeutics, Inc. (NASDAQ:NWBO), Ares Capital Corporation (NASDAQ:ARCC) - Beacon Chronicle (NASDAQ:NWBO)
www.beaconchronicle.com - June 7 at 6:46 PM
News IconPerformance to see: Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) - News Oracle (NASDAQ:NWBO)
www.newsoracle.com - June 7 at 6:46 PM
streetupdates.com logoAnalysts Rating Alert: Allergan plc. (NYSE:AGN) , Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) - Street Updates (NASDAQ:NWBO)
www.streetupdates.com - June 6 at 6:29 PM
capitalcube.com logoETF’s with exposure to Northwest Biotherapeutics, Inc. : June 6, 2016 (NASDAQ:NWBO)
www.capitalcube.com - June 6 at 5:38 PM
streetupdates.com logoRecent Analysts Rating Alert: Allergan (AGN) , Northwest Biotherapeutics, (NWBO) - Street Updates (NASDAQ:NWBO)
www.streetupdates.com - June 6 at 10:13 AM
equities.com logoNorthwest Biotherapeutics Inc. (NWBO) Hits New 52-week Low During June 01 Session - Equities.com (NASDAQ:NWBO)
www.equities.com - June 3 at 9:26 AM
equities.com logoNorthwest Biotherapeutics Inc. (NWBO) Drops 5.41% on May 26 - Equities.com (NASDAQ:NWBO)
www.equities.com - May 27 at 11:43 PM

Social

Northwest Biotherapeutics (NASDAQ:NWBO) Chart for Thursday, August, 25, 2016


Last Updated on 8/25/2016 by MarketBeat.com Staff